Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders in women of reproductive age, and the most frequent cause of hyperandrogenism and oligo-anovulation. 
Cushing' s syndrome).
The institutional review board of the Ewha Womans
University Mokdong Hospital approved the study protocol, and written informed consent was obtained from all of the participants.
Methods

1) Anthropometric measurements
A through physical examination was performed. Weight, height, waist circumference and hip circumference were measured. Body mass index (BMI) and waist-to-hip ratio (WHR) were calculated. The total number of follicles was determined by counting two to nine millimeter sized follicles observed during a scan of the ovary' s longitudinal cross-section. The ovarian volume was calculated using length (cm) × width (cm) × thickness (cm) × 0.523. Patients with ovarian cysts or a history of ovarian surgery were excluded from this study.
2) Laboratory measurement
4) Classification of subgroups
According to HOMA-IR levels, PCOS patients were classified into four groups (Table 1) .
Statistics
Statistical analysis was performed using SPSS version (Table 3) .
Discussion
As insulin resistance is the reduction in the biological effect of insulin' s metabolic action, 8 it is a major mechanism of metabolic feature in PCOS, that is closely linked with a rise in cardiovascular risk among PCOS patients.
Nevertheless, the consensus in measuring insulin resistance in PCOS patients is lacking. Therefore, in this study, Additionally, menopause may be related with the prevalence of metabolic syndrome and increased cardiovascular disease and diabetes. 15 In postmenopausal Korean women who had received combined estrogen and progesterone therapy, or tibolone, the levels of TC decreased although a prospective study including a larger group will be required. 16 Recent menopausal data suggest that the majority of women who had PCOS during their reproductive years continue to manifest cardiovascular risk factors. 17 Moving from the young fertile age to the 40s and the menopause the prevalence of type II diabetes continues to increase compared to the general female population and may reach 10-16% of PCOS women. 18 After 20 years of follow-up in women with PCOS, androgens and ovarian volume decreased and there were more ovulatory cycles suggesting a milder disorder, whereas metabolic abnormalities persisted and waist circumference increased. 19 However, the welldescribed cardiovascular/metabolic risk profile in pre-and perimenopausal PCOS women does not entail an evident increase in cardiovascular events during the postmenopausal period. 20 Because whether PCOS itself causes an increased cardiovascular disease risk later in life is still uncertain, additional longitudinal study for following women with PCOS into menopause will help to determine continuous careful investigations and screening for cardiovascular disease. 
